loading
Schlusskurs vom Vortag:
$4.00
Offen:
$3.99
24-Stunden-Volumen:
137.51K
Relative Volume:
0.20
Marktkapitalisierung:
$503.63M
Einnahmen:
$433.14M
Nettoeinkommen (Verlust:
$4.95M
KGV:
111.20
EPS:
0.0357
Netto-Cashflow:
$6.55M
1W Leistung:
-5.13%
1M Leistung:
-7.34%
6M Leistung:
-24.72%
1J Leistung:
+32.94%
1-Tages-Spanne:
Value
$3.965
$4.07
1-Wochen-Bereich:
Value
$3.94
$4.39
52-Wochen-Spanne:
Value
$2.6101
$6.71

Organogenesis Holdings Inc Stock (ORGO) Company Profile

Name
Firmenname
Organogenesis Holdings Inc
Name
Telefon
781-575-0775
Name
Adresse
85 DAN ROAD, CANTON, MA
Name
Mitarbeiter
869
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
ORGO's Discussions on Twitter

Vergleichen Sie ORGO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
ORGO
Organogenesis Holdings Inc
3.97 507.43M 433.14M 4.95M 6.55M 0.0357
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
126.85 63.97B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.62 42.40B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.335 41.77B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.45 23.54B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
437.13 18.89B 3.08B 1.24B 1.07B 25.61

Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-06-28 Eingeleitet Lake Street Buy
2024-02-07 Eingeleitet Cantor Fitzgerald Overweight
2023-06-15 Eingeleitet Morgan Stanley Equal-Weight
2023-05-24 Hochstufung BTIG Research Neutral → Buy
2022-11-10 Herabstufung BTIG Research Buy → Neutral
2022-08-10 Herabstufung Oppenheimer Outperform → Perform
2020-01-10 Eingeleitet SVB Leerink Outperform
2019-08-26 Fortgesetzt Credit Suisse Outperform
2019-05-02 Eingeleitet Credit Suisse Outperform
2019-04-17 Eingeleitet Oppenheimer Outperform
2019-04-11 Eingeleitet SunTrust Buy
Alle ansehen

Organogenesis Holdings Inc Aktie (ORGO) Neueste Nachrichten

pulisher
05:15 AM

Why Organogenesis Holdings Inc. stock could be next big winnerInsider Buying & Real-Time Buy Signal Notifications - newser.com

05:15 AM
pulisher
05:11 AM

Is Organogenesis Holdings Inc. showing signs of accumulation2025 Trading Volume Trends & Daily Growth Stock Investment Tips - newser.com

05:11 AM
pulisher
04:34 AM

What indicators show strength in Organogenesis Holdings Inc.July 2025 Trade Ideas & Free Real-Time Market Sentiment Alerts - newser.com

04:34 AM
pulisher
03:34 AM

Multi asset correlation models including Organogenesis Holdings Inc.Weekly Investment Report & Expert Curated Trade Ideas - newser.com

03:34 AM
pulisher
Nov 03, 2025

Why pension funds invest in Organogenesis Holdings Inc. (2PQ) stockJuly 2025 Gainers & Safe Capital Growth Stock Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What to expect from Organogenesis Holdings Inc. in the next 30 daysJuly 2025 Action & AI Enhanced Trading Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Using Python tools to backtest Organogenesis Holdings Inc. strategiesTrade Analysis Summary & Safe Swing Trade Setups - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Organogenesis Applauds CMS’s Significant Step In Payment Reform - The Manila Times

Nov 03, 2025
pulisher
Nov 03, 2025

Organogenesis Holdings Inc. Commends CMS on Payment Reform for Skin Substitutes and CTPs Under CY 2026 Fee Schedule - Quiver Quantitative

Nov 03, 2025
pulisher
Nov 03, 2025

Organogenesis (Nasdaq: ORGO) applauds CMS 2026: per‑cm payments, FDA classifications finalized - Stock Titan

Nov 03, 2025
pulisher
Nov 03, 2025

Is Organogenesis Holdings Inc. stock positioned for digital transformation2025 Trade Ideas & Verified Swing Trading Watchlist - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Organogenesis Holdings Inc. stock maintain momentum in 2025Trade Risk Summary & Weekly High Potential Stock Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Asia Pacific Wound Care Biologics Market Growth in Future Scope - openPR.com

Nov 03, 2025
pulisher
Nov 03, 2025

Should I hold or sell Organogenesis Holdings Inc. stock in 2025July 2025 Setups & High Accuracy Investment Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Organogenesis Holdings Inc. outperform the marketJuly 2025 Short Interest & Growth Focused Entry Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Real time pattern detection on Organogenesis Holdings Inc. stockJuly 2025 Update & Verified Momentum Stock Watchlist - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Detecting price anomalies in Organogenesis Holdings Inc. with AIJuly 2025 Institutional & Risk Controlled Daily Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Organogenesis Holdings Inc. stock oversold or undervalued2025 Market Sentiment & Short-Term High Return Ideas - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Is Organogenesis Holdings Inc. (2PQ) stock at risk of policy regulationWeekly Volume Report & Weekly Market Pulse Updates - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Has Organogenesis Holdings Inc. formed a bullish divergenceJuly 2025 Setups & Free Weekly Chart Analysis and Trade Guides - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Why Organogenesis Holdings Inc. (2PQ) stock stays on top picksWeekly Profit Analysis & Reliable Entry Point Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Organogenesis Holdings Inc. (ORGO) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Nov 02, 2025
pulisher
Nov 02, 2025

Why Organogenesis Holdings Inc. stock is trending among retail tradersBond Market & Long-Term Growth Plans - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Can Organogenesis Holdings Inc. rally from current levelsWeekly Trend Summary & Low Risk Entry Point Guides - newser.com

Nov 02, 2025
pulisher
Oct 31, 2025

Organogenesis Holdings Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Oct 31, 2025
pulisher
Oct 31, 2025

Organogenesis (NASDAQ: ORGO) awards CTO inducement equity at $4.17, 4-year vesting - Stock Titan

Oct 31, 2025
pulisher
Oct 31, 2025

Organogenesis Holdings Inc. (ORGO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Oct 31, 2025
pulisher
Oct 31, 2025

Top chart patterns to watch in Organogenesis Holdings Inc.July 2025 Update & High Yield Stock Recommendations - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-31 05:50:02 - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-31 03:32:15 - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

What high frequency data says about Organogenesis Holdings Inc.July 2025 Drop Watch & Weekly Watchlist for Consistent Profits - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Organogenesis Holdings Inc. (ORGO) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

Oct 30, 2025

Finanzdaten der Organogenesis Holdings Inc-Aktie (ORGO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Organogenesis Holdings Inc-Aktie (ORGO) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
NUSSDORF GLENN H
Director
May 15 '25
Buy
2.99
107,494
320,999
358,495
NUSSDORF GLENN H
Director
Jun 10 '25
Sale
3.56
18,620
66,256
335,719
NUSSDORF GLENN H
Director
Jun 09 '25
Sale
3.50
4,156
14,547
354,339
Grow Brian
Chief Commercial Officer
Aug 11 '25
Option Exercise
2.47
4,060
10,028
674,550
Freedman Lori
Chief Admin. and Legal Officer
Jun 05 '25
Buy
2.91
142,379
413,625
837,437
Freedman Lori
Chief Admin. and Legal Officer
Jun 04 '25
Buy
2.82
100,863
284,716
695,058
Freedman Lori
Chief Admin. and Legal Officer
Jun 06 '25
Buy
2.99
9,022
26,949
846,459
$44.73
price up icon 0.71%
drug_manufacturers_specialty_generic RDY
$13.48
price up icon 0.56%
$22.81
price down icon 0.15%
$10.60
price up icon 0.60%
$142.32
price up icon 0.18%
$437.68
price down icon 0.22%
Kapitalisierung:     |  Volumen (24h):